Table 2 Response to induction therapy according to treatment strategy.

From: Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide—an International Collaborative Study

% (N)

CTX/ATRA

N = 407

ATO/ATRA

N = 26

CR

82 (332)

92 (24)

RD

0.5 (2)

–

ID

18 (73)

8 (2)

  1. Missing data, n = 3 (CTX/ATRA). Percentages may not add to 100 because of rounding.
  2. ATO arsenic trioxide, ATRA all-trans retinoic acid, CR complete remission, CTX chemotherapy, ID induction death, N numbers, RD resistant disease.
Back to article page